Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
Under therapeutic pressure aggressive tumors evolve rapidly. Herein, a luminal B/HER2-low breast cancer was tracked for >3 years during a total of 6 largely unsuccessful therapy lines, from adjuvant to advanced settings. Targeted next generation sequencing (NGS) of the primary lesion, two met...
Main Authors: | Matteo Allegretti, Vittoria Barberi, Cristiana Ercolani, Antonello Vidiri, Elena Giordani, Gennaro Ciliberto, Patrizio Giacomini, Alessandra Fabi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1050452/full |
Similar Items
-
The Role of Erythrocyte Sedimentation Rate (ESR) in Myeloproliferative and Lymphoproliferative Diseases: Comparison between DIESSE CUBE 30 TOUCH and Alifax Test 1
by: Martina Pelagalli, et al.
Published: (2023-11-01) -
Estrogen and Glycemic Homeostasis: The Fundamental Role of Nuclear Estrogen Receptors ESR1/ESR2 in Glucose Transporter GLUT4 Regulation
by: Karen Cristina Rego Gregorio, et al.
Published: (2021-01-01) -
Hyperfine Decoupling of ESR Spectra Using Wavelet Transform
by: Aritro Sinha Roy, et al.
Published: (2022-03-01) -
Evaluation of Stability and Accuracy Compared to the Westergren Method of ESR Samples Analyzed at VES-MATIC 5
by: Maria Lorubbio, et al.
Published: (2024-03-01) -
Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma
by: Paula González-Alonso, et al.
Published: (2015-08-01)